Ivan Muradore
Impact in
- Genetics top 10%
- Mesenchymal stem cell research
- Hematology top 10%
- Acute Myeloid Leukemia Research
Papers in
-
- Protein Degradation and Inhibitors 2
- Glycosylation and Glycoproteins Research 1
- Ubiquitin and proteasome pathways 1
- Epigenetics and DNA Methylation 1
- Histone Deacetylase Inhibitors Research 1
-
- Acute Myeloid Leukemia Research 2
- Chronic Myeloid Leukemia Treatments 1
- Co-authors
- Simona Ronzoni (3 shared papers)Myriam Alcalay (2 shared papers)Andrea Viale (2 shared papers)Christian Seiser (1 shared paper)Giulio Draetta (1 shared paper)Daniela Bossi (2 shared papers)Pier Giuseppe Pelicci (2 shared papers)Saverio Minucci (2 shared papers)
- Journals
- British Journal of Cancer (2 papers)EMBO Reports (1 paper)Nature (1 paper)Molecular and Cellular Biology (1 paper)Leukemia (1 paper)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Ivan Muradore
9 papers receiving 798 citations
Peers
Comparison fields: 5 of 81
- Genetics 109
- Hematology 114
- Cancer Research 118
- Oncology 195
- Molecular Biology 522
Countries citing papers authored by Ivan Muradore
This map shows the geographic impact of Ivan Muradore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Muradore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Muradore more than expected).
Fields of papers citing papers by Ivan Muradore
This network shows the impact of papers produced by Ivan Muradore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Muradore. The network helps show where Ivan Muradore may publish in the future.
Co-authors
The 25 scholars most cited alongside Ivan Muradore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 254 | |
| 2 | 2007 | 218 | |
| 3 | 2014 | 107 | |
| 4 | 2004 | 75 | |
| 5 | 2002 | 55 | |
| 6 | 2015 | 42 | |
| 7 | 2000 | 32 | |
| 8 | 2011 | 30 | |
| 9 | 2002 | 8 | |
| 10 | 2023 | 0 |
About Ivan Muradore
Ivan Muradore is a scholar working on Molecular Biology, Hematology, Immunology, Genetics and Cancer Research, having authored 10 papers that have together received 821 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (2 papers), Synthesis and Biological Activity (2 papers), Protein Degradation and Inhibitors (2 papers), Chronic Myeloid Leukemia Treatments (1 paper), Glycosylation and Glycoproteins Research (1 paper), Ubiquitin and proteasome pathways (1 paper), Epigenetics and DNA Methylation (1 paper) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Genetics (109 citations), Hematology (114 citations), Cancer Research (118 citations), Oncology (195 citations) and Molecular Biology (522 citations). Ivan Muradore has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Simona Ronzoni, Myriam Alcalay, Andrea Viale, Christian Seiser, Giulio Draetta, Daniela Bossi, Pier Giuseppe Pelicci, Saverio Minucci, Silvia Senese and Susanna Chiocca. Their work appears in journals such as British Journal of Cancer, EMBO Reports, Nature, Molecular and Cellular Biology and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.